Courses | Page 2 | AUA University

Topic

Core Curriculum Related Education

Title	Category	Credit	Event Date	Price
Life Long Learning Prep Course Webcast: Module 2: Calculi, Laparoscopy-Robotics and Upper Tract Obstruction (2021)				$1,055.00	Specifically designed for anyone unable to get away from the office to attend the Live Course, the Webcast option delivers the same great content. Purchase of the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials.
PARPi: Genetic Testing in Advanced Prostate Cancer - When and Who to Test Webcast (2023)		1.00 AMA PRA Category 1 Credit™ 1.00 Non-Physician Participation		$0.00	The American Urological Association (AUA) has developed a series of live virtual and on-demand educational offerings to further address the identified educational gaps and barriers in advanced prostate cancer care. Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessments, a three-part educational series to update urologists and advanced practice providers (APPs) on PARP-inhibitor (PARPi) treatment in advanced prostate cancer is being offered.
Advances in ADT Part II: A Guide for Urologists Webcast (2023)		1.00 AMA PRA Category 1 Credit™ 1.00 Non-Physician Participation		$0.00	Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessment, the AUA has created Advances in ADT: Part II: A Guide for Urologists (2023), an educational offering to further update urologists on the latest advancements in androgen deprivation therapy (ADT) and prostate cancer treatment.
Prostate Cancer Diagnosis: AUA Guidelines on use of PSA Biomarkers, MRI and Biopsy Techniques Webcast (2024)		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	Prostate cancer detection remains one of the most common and most controversial aspects of urological practice. In addition to the complexities around screening and use of PSA, the role of other biomarkers, biopsy techniques such as transperineal biopsy and MRI for targeted biopsy are evolving rapidly. This course is intended for urologists, advanced practice providers and trainees interested in using the most evidence-based methods for optimizing detection of clinically important prostate cancers, while improving patient experience and minimizing complications.
Global Advancements in Bladder Cancer Webcast (2023)		1.50 AMA PRA Category 1 Credit™ 1.50 Non-Physician Participation		$0.00
Practical Implementation of Third-Line Therapies for Refractory Overactive Bladder (OAB) Webcast (2024)		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	Learners will be presented with case-based and guidelines-based information regarding when to introduce third-line therapies to patients for potentially refractory overactive bladder (OAB), presentation (scripting) techniques to impart important information to patients with user-friendly comprehensible language and analogies to help the patients receive the counseling, pros and cons of each of the third-line therapies, technical tips on optimal delivery of the three third-line therapies and how to select which therapies are the best fit for a given patient.
Practice Management & Coding Program Webcast (2022)				$1,095.00	Management, Leadership and Coding for Your Urology Practice! This two session webcast combines the AUA’s ever popular Practice Management Conference and annual Coding Seminar into one comprehensive course offering. The purpose of this webcast is to educate physicians and non-physicians alike on the topics impacting the management of today’s urology practice with an increased emphasis on coding and reimbursement.
Incorporating Genomic Testing and Advanced Imaging For Prostate Cancer Into Your Practice Webcast (2024)		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	There are multiple genomic tests and advanced imaging modalities (MRI, prostate-specific membrane antigen PET, etc.) currently available for men to detect and risk-stratify prostate cancer. The outcomes of these tests may lead to different detection strategies (observation, immediate biopsy, etc.) and treatment decisions (active surveillance, surgery, radiation, adjuvant therapy, etc.). We will also discuss germline testing as inherited mutations have considerable implications for screening, treatment, genetic counseling and cascade testing of family members.
Building a Primary Palliative Care Model for Urology Webcast (2021)		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	Building a Primary Palliative Care Model for Urology Webcast (2021) discusses aspects of palliative care that benefit patients, the urologist’s role and their collaboration with palliative care clinicians including:
Chemotherapy and Immunotherapy for the Urologist and Advanced Practice Provider Webcast (2024)		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	This is a repeat course from prior years, with review of advanced and metastatic prostate, bladder and kidney cancer. Most recent treatment guidelines are reviewed along with the studies that support them. Different disease spaces in oncologic care are discussed, including the medications used to treat them, their mechanism, side effects and efficacy. Role of the advanced practice provider is discussed for each tumor type. Finally, cases are presented along with management options for audience participation.
Life Long Learning Prep Course Webcast: Module 3: Impotence, Infertility and Andrology (2021)				$1,055.00	Specifically designed for anyone unable to get away from the office to attend the Live Course, the Webcast option delivers the same great content. Purchase of the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials.
PARPi: Management of Adverse Events Webcast (2024)		1.00 AMA PRA Category 1 Credit™ 1.00 Non-Physician Participation		$0.00	The American Urological Association (AUA) has developed a series of live virtual and on-demand educational offerings to further address the identified educational gaps and barriers in advanced prostate cancer care. Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessments, a three-part educational series to update urologists and advanced practice providers (APPs) on PARP-inhibitor (PARPi) treatment in advanced prostate cancer is being offered.
Advances in ADT Part II: A Guide for APPs Webcast (2023)		1.00 AMA PRA Category 1 Credit™ 1.00 Non-Physician Participation		$0.00	Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessment, the AUA has created Advances in ADT: Part II: A Guide for APPs (2023), an educational offering to further update APPs on the latest advancements in androgen deprivation therapy (ADT) and prostate cancer treatment. This educational initiative is comprised of multiple formats, including a live course and on-demand webcast. This live virtual course, which is the cornerstone of the initiative features a multidisciplinary panel, engaging in a lively discussion.
How to use Prostate-Specific Membrane Antigen-Positron Emission Tomography/CT in the Management of Relapsing Prostate Cancer Patients following Local...		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	The learners will understand the following critical clinical aspects with regard to the clinical application of prostate-specific membrane antigen (PSMA) PET/CT; scanning mode of action of PSMA PET/CT; pitfalls of PSMA PET/CT; diagnostic accuracy depending on PSA, PSA double time, prostate cancer histology; application of PSMA PET/CT to identify patients with intrapelvic nodal relapse who will benefit from local therapy such as salvage lymphadenectomy or stereotactic radiation therapy; application of PSMA PET/CT to identify patients with organ-confined radiorecurrent local relapse of prosta
Treatment for Hormone Sensitive Prostate Cancer Webcast (2023)		1.00 AMA PRA Category 1 Credit™ 1.00 Non-Physician Participation		$0.00

Pages